BRAF and cutaneous melanoma: Genomic analyses have revealed that oncogenic mutations in genes such as BRAF and NRAS dominate the landscape of cutaneous melanoma, frequently initiating aberrant signaling pathways that foster unchecked cellular proliferation and survival (9–11).